Avian flu has been on the American public health watch list due to its increasing detection in wild birds, poultry, cows, and other animals. In recent cases, mild avian flu infections have been contracted by dairy workers, while evidence of the virus is being detected in wastewater surveillance. The most severe case appeared in Missouri, with no known source, and a patient in Louisiana became the first confirmed death from avian flu in the US.
A 2023 incident on a French Riviera cruise ship showcased the challenges of diagnosing and containing avian flu outbreaks. A rapid antigen test detected cases not identified by standard influenza A testing. To prevent future outbreaks, it’s crucial to have avian flu testing at the front lines with FDA-approved tests available for early detection.
Consequently, healthcare systems should prioritize early detection, self-isolation, and treatment of suspected avian flu patients. With two FDA-approved tests available, one of which detects results in 15 minutes or less, rapid testing can help minimize transmission. Government funding has been provided to develop more testing options, but state governors must take action to encourage and sponsor large healthcare systems to test for avian flu.
Medical centers can lead the way by upgrading protocols for use in emergency departments and urgent care facilities, sharing data with state leadership, and establishing drive-in or walk-in testing centers. The goal is to prepare for the worst-case scenario of human-to-human transmission, where vaccines against avian flu may be available soon. By promoting early diagnosis and reduced community transmission, state leaders can prevent a local outbreak from becoming an external threat.
Source: https://www.medpagetoday.com/opinion/second-opinions/114127